New Developments in Intrauterine Contraception – Background

Intrauterine Contraception: Filling an Unmet Need Intrauterine contraception (IUC), which includes the use of various intrauterine devices (IUDs) and the levonorgestrel intrauterine system (LNG IUS), is as effective as sterilization, is not dependent on user …

Photo of author

Written by: Audrey Kelly, PharmD

Published on:

Intrauterine Contraception: Filling an Unmet Need Intrauterine contraception (IUC), which includes the use of various intrauterine devices (IUDs) and the levonorgestrel intrauterine system (LNG IUS), is as effective as sterilization, is not dependent on user motivation for effectiveness, and, according to a July 2004 ARHP survey, is one of the highest-rated methods for patient satisfaction. Millions of women throughout the world use IUC. In the United States, IUC use has been hampered by several factors, including limitations to access and persistent myths about associated adverse events. While fading, these myths still exist, restricting more widespread adoption of IUC. With this issue of Clinical Proceedings®, we hope to educate providers so they can feel more comfortable offering intrauterine contraception as a useful and effective option for their patients. My sincere thanks to the members of our advisory committee for their investment of time and expertise: David Grimes, MD; Kirtly Parker Jones, MD; Susan Wysocki, RN-C, NP; and Chris Knutson, MN, ANP. Wayne C. Shields ARHP President and CEO

Intrauterine Contraception: Filling an Unmet Need

Intrauterine contraception (IUC), which includes the use of various intrauterine devices (IUDs) and the levonorgestrel intrauterine system (LNG IUS), is as effective as sterilization, is not dependent on user motivation for effectiveness, and, according to a July 2004 ARHP survey, is one of the highest-rated methods for patient satisfaction. Millions of women throughout the world use IUC. In the United States, IUC use has been hampered by several factors, including limitations to access and persistent myths about associated adverse events. While fading, these myths still exist, restricting more widespread adoption of IUC.

With this issue of Clinical Proceedings®, we hope to educate providers so they can feel more comfortable offering intrauterine contraception as a useful and effective option for their patients.

My sincere thanks to the members of our advisory committee for their investment of time and expertise: David Grimes, MD; Kirtly Parker Jones, MD; Susan Wysocki, RN-C, NP; and Chris Knutson, MN, ANP.

Wayne C. Shields
ARHP President and CEO

Photo of author

About Audrey Kelly, PharmD

Drug Integrity Associate Audrey Amos is a pharmacist with experience in health communication and has a passion for making health information accessible. She received her Doctor of Pharmacy degree from Butler University. As a Drug Integrity Associate, she audits drug content, addresses drug-related queries
More from this author

Leave a Comment

Previous

Fish Consumption to Promote Good Health and Minimize Contaminants – References

Next

Managing Premenstrual Symptoms – Treatment